Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download innovative self-injection solutions
Document related concepts
Transcript
sterile technologies INNOVATIVE SELF-INJECTION SOLUTIONS from two of the most respected names in drug delivery: Catalent and Bespak. Combined expertise, reliable supply. The ASI™ autoinjector technology platform and the new OTS™ autoinjector device provide simple, cost-effective solutions for self-injection. Experienced Over 100 years of combined experience in providing drug delivery technologies for the global pharmaceutical industry. Cost-effective Autoinjector devices, syringe filling, device assembly and packaging providing economic solutions for final product supply. Responsive Manufacturing and supply of autoinjector devices from pilot-scale through commercial supply, with full supply chain management. Superiority of the ASI™ autoinjector platform. The ASI™ autoinjector is a patented, single-use technology platform designed to accommodate pre-filled syringes. This technology allows patients or other non-clinicians to undertake comfortable, safe injections by hiding the needle at all times, automatically retracting the needle after injection and securing it safely within the used device. These devices also offer two-step “push” and three-step “button” actuation options. Tailored Design Devices can be configured to accommodate a customer’s preferred pre-filled syringe and can be adapted for a range of fill and delivery volumes, as well as speed and depth of injection, to meet the requirements of specific customers, therapies and patient populations. Viscous Drug Delivery The proprietary Compression Pad feature means that Bespak’s autoinjectors are well-suited for delivery of viscous formulations, helping to avoid damage to glass syringes that can result from application of elevated injection forces. DEVELOPMENTDELIVERY SUPPLY OTS™ autoinjector device: optimal solution. The new OTS™ autoinjector is a market-ready device, based on Bespak’s patented ASI™ autoinjector platform. Industry Standard The OTS™ autoinjector device is designed to incorporate an industry-standard 1ML “long” pre-filled syringe with staked needle. Choice Options include a two-step “push” and three-step “button” actuation making the OTS™ autoinjector suitable for a range of patient populations with differing physical capabilities. Viscous Liquids The OTS™ autoinjector is designed to allow for the delivery of liquids with viscosities up to 40Cps through 27g or 29g needles. Cost-effective Solutions For a standardized primary pack configuration, the OTS™ autoinjector can support new and existing drug products, product pipelines and product lifecycle management strategies. Meeting market needs. The OTS™ autoinjector can be supplied either “off-the-shelf” or optimized to address specific needs relating to actuation mechanism, injection volume and external device geometry, without the time, cost and risk associated with more extensive device customization. Flexible Supply The OTS™ autoinjector can be supplied in volumes ranging from sample quantities to facilitate early-stage decision making through high volumes for marketed products. Catalent and Bespak provide flexible, high performance autoinjector options through our partnered approach. Our success is our customers’ success. Discover more solutions with Catalent: more products. better treatments. reliably supplied.™ Catalent Pharma Solutions www.catalent.com [email protected] ASI™ and OTS™ are trademarks belonging to Bespak Europe Ltd. All rights reserved. © Copyright 2011 Catalent Pharma Solutions and Bespak. All right reserved. ST-PFS-AI-SSV2 (6/11) 14 Schoolhouse Road Somerset, NJ 08873 USA T + 1 866 720 3148 F + 1 732 537 6480 14 Schoolhouse Road Somerset, NJ 08873 USA T + 1 866 720 3148 F + 1 732 537 6480
